Abstract: Described herein are methods for preventing a serious health consequence and/or tissue damage in a subject after the subject has been exposed to ionizing radiation and/or chemotherapy. The methods involve administering to the subject a sulfated polysaccharide or the pharmaceutically acceptable salt or ester thereof after the subject has been exposed to ionizing radiation and/or chemotherapy. The methods described herein are most beneficial to cancer patients who suffer from mucositis after exposure to ionizing radiation.
Type:
Grant
Filed:
June 3, 2019
Date of Patent:
May 9, 2023
Assignee:
GLYCOMIRA THERAPEUTICS, INC.
Inventors:
Won Yong Lee, Abigail Pulsipher, Thomas P. Kennedy, Justin Rodney Savage, Glenn Prestwich